Despite a challenging macro environment, NCS demonstrated strong operational execution and margin expansion. The company's asset-light model and international growth, particularly in the North Sea and Middle East, position it well for continued outperformance. Traders should monitor 2026 guidance for signs of sustained momentum, especially in U.S. market share gains and integration of ResMetrics.
Price Chart
Executive Summary
NCS Multistage reported strong fourth quarter and full-year 2025 results with 13% year-over-year revenue growth to $183.6 million and a 20% increase in Adjusted EBITDA to $26.7 million. Net income surged to $23.7 million, boosted by a $11.5 million tax benefit from the release of a deferred tax valuation allowance. The company also improved free cash flow to $18.9 million and strengthened its balance sheet with $36.7 million in cash.
Key Financial Metrics
Key Facts
- Total revenues of $183.6 million in 2025, up 13% year-over-year
- Adjusted EBITDA of $26.7 million, up 20% YoY with margin expansion to 15%
- Net income of $23.7 million ($8.65 per diluted share), including $11.5 million tax benefit
- Free cash flow after distributions to non-controlling interest reached $18.9 million, up $9.0 million YoY
- Ended 2025 with $36.7 million in cash and $7.6 million in debt
- Acquired ResMetrics in July 2025, which contributed $5.2 million in revenue
Financial Impact
Revenue increased by $21.0 million and net income by $17.1 million year-over-year, with a significant $11.5 million one-time tax benefit contributing to profitability
Risk Factors
- 2026 outlook anticipates lower U.S. customer activity and flat performance in Canada
- Free cash flow benefit was partially driven by working capital changes, which may not be recurring
- Adjusted net income excluding one-time items is significantly lower at $11.0 million
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249735 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | Court Ruling | — | awaiting T+1 | — | — |
Sep 11, 2026 21d ago | 15-12G | — | awaiting T+1 | — | — |
Sep 9, 2026 23d ago | EFFECT | — | awaiting T+1 | — | — |
Sep 9, 2026 23d ago | EFFECT | — | awaiting T+1 | — | — |
Sep 1, 2026 4w ago | 25-NSE | $53.35 $53.35 | · 0.00% | ▼ −0.44% | — |
Sep 1, 2026 4w ago | 8-K | $53.35 $53.35 | · 0.00% | ▼ −0.44% | — |
Jul 30, 2026 9w ago | Press Release | $47.00 $47.13 | ▼ −0.28% | ▲ +1.15% | — |
Jun 1, 2026 17w ago | 425 | $55.60 $55.72 | ▲ +0.22% | ▲ +0.94% | — |
Jun 1, 2026 17w ago | 425 | $55.60 $55.72 | ▲ +0.22% | ▲ +0.94% | — |
Jun 1, 2026 17w ago | 425 | $55.60 $55.72 | ▲ +0.22% | ▲ +0.94% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access